In eukaryotic protein synthesis the translation initiation factor 3 (eIF3) is a key player in the recruitment and assembly of the translation initiation machinery. Mammalian eIF3 consists of 13 subunits, including the loosely associated eIF3j subunit that plays a stabilizing role in the eIF3 complex formation and interaction with the 40S ribosomal subunit. By means of both co-immunoprecipitation and mass spectrometry analyses we demonstrate that the protein kinase CK2 interacts with and phosphorylates eIF3j at Ser127. Inhibition of CK2 activity by CX-4945 or down-regulation of the expression of CK2 catalytic subunit by siRNA cause the dissociation of j-subunit from the eIF3 complex as judged from glycerol gradient sedimentation. This finding proves that CK2-phosphorylation of eIF3j is a prerequisite for its association with the eIF3 complex. Expression of Ser127Ala-eIF3j mutant impairs both the interaction of mutated j-subunit with the other eIF3 subunits and the overall protein synthesis. Taken together our data demonstrate that CK2-phosphorylation of eIF3j at Ser127 promotes the assembly of the eIF3 complex, a crucial step in the activation of the translation initiation machinery.
Introduction
In eukaryotic protein synthesis, initiation of translation is a complex sequence of reactions requiring the interaction of the ribosome with a number of eukaryotic translation initiation factors (eIFs). A key player in the recruitment and assembly of the translation initiation machinery is the multiprotein complex eIF3, which stimulates many steps of the pathway. These include assembly of the eIF2-GTP/met-tRNAi complex and of other eIFs to the 40S ribosomal subunit to form the 43S preinitiation complex, recruitment of mRNA to the 43S complex, prevention of the 40S ribosome from joining the 60S prematurely, and the scanning of mRNA for AUG recognition [reviewed in 1, 2] . In mammals, eIF3 contains 13 different subunits, which are named IF3a to eIF3m in order of decreasing molecular weight, and possesses an anthropomorphic five-lobed structure [3] organized around a functional core complex [4, 5] . Structural analysis suggests that eIF3 performs a scaffolding function by binding to the 40S subunit on its solventexposed surface rather than on its interface with the 60S subunit, where the decoding sites are located [3] . This location of eIF3 seems ideally suited for its other proposed regulatory functions, including its acting as a receptor for protein kinases that control protein synthesis [6, 7] . eIF3j is a nonstoichiometric and highly conserved subunit, that is loosely associated with the eIF3 complex [8, 9] . It makes multiple independent interactions with the eIF3 core [5] and its binding to the eIF3b N-terminal RNA recognition motif plays a stabilizing role in forming the eIF3 complex [10] . eIF3j is required for high-affinity binding of eIF3 to the 40S ribosomal subunit, it associates with the decoding center of the 40S subunit and governs the binding of initiation factors and mRNA to form a scanning-competent initiation complex [8, 9, [11] [12] [13] . It has been also proposed that eIF3j promotes mRNA dissociation during the ribosomal recycling step [14] .
Protein kinase CK2 is a ubiquitous, highly conserved and pleiotropic Ser/Thr kinase, endowed with constitutive activity, independent of any known second messenger or phosphorylation events. The kinase is usually present as a tetrameric holoenzyme composed of two catalytic subunits (α and/or α′) and two non-catalytic β-subunits. CK2 phosphorylates a huge number of protein substrates, implicated in fundamental cell processes. Among the CK2 substrates there are also transcription factors, modulators of DNA and RNA structure, and proteins involved in RNA and protein biosynthesis, which highlight the 
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Biochimica et Biophysica Acta j o u r n a l h o m e p a g e : w w w . e l s e v i e r . c o m / l o c a t e / b b a m c r importance of CK2 in controlling gene expression [15, 16] . CK2 is abnormally elevated in a wide variety of tumors, where it plays a global role as an anti-apoptotic and pro-survival agent operating as a cancer driver by creating a cellular environment favorable to neoplasia [17] [18] [19] .
In this study we show that the protein kinase CK2 interacts with and phosphorylates the j subunit of the eIF3 complex. CK2-catalyzed phosphorylation of eIF3j triggers the association of this subunit with eIF3 complex promoting an efficient translation initiation.
Materials and methods

Materials and antibodies
[γ- 33 P]ATP was purchased from Hartmann Analytic GmbH (Braunschweig Germany). Protease inhibitor cocktail was from Calbiochem (Darmstadt, Germany), while phosphatase inhibitor cocktails 2 and 3 and the kit for molecular weight markers were from Sigma-Aldrich (Dorset, UK). CX-4945 was purchased from AbMole BioScience (Hong Kong, China), staurosporine from Sigma-Aldrich (Dorset, UK) and quinalizarin was kindly provided by Dr. G. Cozza, University of Padova, Italy [20] . RRRADDSDDDDD peptide [21] and recombinant CK2 (α 2 β 2 ) [22] were kindly provided by Dr. Oriano Marin and Dr. Andrea Venerando (University of Padova, Italy), respectively. Antiserum against CK2α subunit was raised in rabbit using the peptide reproducing the sequence of the human catalytic subunit at the C-terminus (376-391). The peptide was coupled to keyhole limpet hemocyanin using m-maleimidobenzoyl-N-hydroxysuccinimide ester (Fischer Scientific, Illkirch Cedex, France). Anti-CK2β antibody was from Epitomics (Burlingame, CA), while antibodies raised against Fyn, eIF3j, eIF3b, eIF3c, eIF3d, and rpS6 were from Santa Cruz Biotechnology (Santa Cruz, CA). AntiAkt1 (phospho-129) was from Abcam (Cambridge, UK), anti-Akt1 from Cell Signaling Technology (Danvers, MA), while anti-β-actin and anti-c-Myc were purchased from Sigma-Aldrich.
Cell culture
HEK293 (human embryonic kidney) and Hela (cervical cancer) cells were grown in DMEM, while LAMA84 (chronic myeloid leukemia) cells were maintained in RPMI 1640. Both media were supplemented with 10% fetal calf serum, 2 mM L-glutamine, 100 U/ml penicillin and 100 mg/ml streptomycin.
Cell lysis and western blot analysis
Cells were lysed by suspension (1 h at 4°C) in the lysis buffer containing 20 mM Tris-HCl (pH 7.5), 1% Triton X-100, 10% glycerol, 1 mM EDTA, 150 mM NaCl and protease and phosphatase inhibitor cocktails. After centrifugation (16,000 × g for 15 min) protein concentration was determined in the supernatants by Bradford method. Proteins were subjected to 11% SDS-PAGE, blotted on Immobilon-P membranes (Sigma-Aldrich), processed in western blot with the indicated antibodies and developed using an enhanced chemiluminescent detection system (ECL). Immunostained bands were quantified by means of a Kodak-Image-Station 4000MM-PRO and analysis with Carestream Molecular Imaging software (New Haven, CT).
Immunoprecipitation experiments
Proteins from cell lysates (400 μg in 250 ml) were immunoprecipitated overnight with the specific antibody, followed by addition of protein A-Sepharose for 30 min. The immunocomplexes, washed three times with 0.9 ml of 50 mM Tris-HCl, pH 7.5, were analyzed by westernblot or tested for CK2 activity by in vitro phosphorylation assay.
Phosphorylation assay of immunoprecipitates
Anti-CK2α, anti-eIF3j and anti-Myc immunoprecipitates were phosphorylated in 25 μl of a phosphorylation medium containing 50 mM Tris-HCl (pH 7.5), 10 mM MgCl 2 , 100 mM NaCl and 20 μM [γ- 33 P]ATP (about 1000 c.p.m./pmol). Samples were subjected to SDS-PAGE and blotted. Radioactive proteins were evidenced by a Cyclone Storage Phosphor-Screen (PerkinElmer, Waltham, MA).
Identification of the eIF3j site phosphorylated by CK2
HEK293 cells, treated with vehicle or CX-4945 were immunoprecipitated with eIF3j antibody. Immunocomplexes were loaded on SDS-PAGE and the bands corresponding to the MW of about 35-38 kDa were excised from the gel and digested by trypsin (for details see Supplementary Materials and Methods). The resulting peptides were subjected to a phosphopeptide enrichment step. Samples were dried under vacuum and dissolved in 30 μl of a loading buffer that was constituted of 80% acetonitrile (ACN) and 6% trifluoroacetic acid (TFA, riedel-de Haen). Samples were slowly loaded onto homemade TiO 2 micro-columns (prepared as described in [23] ) preconditioned twice with 20 μl of ACN and twice with 20 μl of loading buffer. Micro-columns were then washed twice with 20 μl of loading buffer and twice with 0.1% TFA (20 μl each time) to increase the pH. Phosphopeptides bound to the stationary phase were finally eluted with 20 μl of freshly prepared NH 4 OH (5%, pH ≈ 11), and released from the C18 frit with a further elution step using 50% ACN, 0.1% formic acid (FA). 2 μl of pure FA was finally added to acidify the samples. Phosphopeptides were dried under vacuum and dissolved in 0.1% FA for mass spectrometry (MS) analysis that was conducted as described in [24] .
Data were analyzed with Proteome Discoverer software (version 1.4, Thermo Fisher Scientific) coupled to a Mascot search engine (version 2.2.4, Matrix Science) against the human section of the Uniprot database (release 20140416, 88708 entries). (For further details see the Supplementary Materials and Methods.) The MS/MS spectra of identified phosphopeptides were manually inspected for confirmation.
Glycerol gradient sedimentation
Cells (10 × 10 6 ) were lysed with the lysis buffer described in Section 2.3 containing 0.2% Triton X-100 and 10 mM KCl (instead of 1% Triton X-100 and 150 mM NaCl, respectively). Lysates (300 μl containing 400 μg of proteins) were layered on the top of a 3.6 ml of a glycerol discontinuous gradient (0.9 ml of 40%, 0.9 ml of 30%, 0.9 ml of 20% and 0.9 ml of 10%) in 50 mM Hepes, pH 8.0, 1 mM EDTA, 1 mM DTT, protease and phosphatase inhibitors. The tubes were centrifuged in a Beckman SW60Ti rotor at 100,000 × g for 18 h at 4°C and fractionated from the bottom into 19 fractions. Fractions (40 μl) were analyzed by western blot.
RNA interference
HEK293 cells (5 × 10 5 ) were transfected for 72 h with 30 nM CK2α and CK2β specific siGENOME SMARTpool siRNAs (Dharmacon, Lafayette, CO, USA) or non-specific siRNA siCONTROL riscfree#1 (Dharmacon). Transfection was performed using the transfecting reagent INTERFERin (Polyplus-transfection SA, Illkirch, France) according to the manufacturer's recommendations.
CK2 kinase activity assay
Proteins from cell lysates were incubated for 10 min at 30°C in 25 μl of a phosphorylation medium containing 50 mM Tris-HCl (pH 7.5), 100 mM NaCl, 12 mM MgCl 2 , 400 μM synthetic peptide-substrate RRRADDSDDDDD and 20 μM [γ-
33 P]ATP (1000 cpm/pmol). Assays were stopped by absorption onto phosphocellulose filters. Filters were washed four times in 75 mM phosphoric acid [21] and analyzed by a Scintillation Counter (PerkinElmer).
Plasmids and cell transfection
pCMV-Myc vector, pCMV-Myc-wild type eIF3j and pCMV-Myc-S127A-eIF3j were purchased from GenScript (Piscataway, NJ, USA). HEK293 cells (1 × 10 6 ) were transfected for 96 h with 4.5 μg of the indicated constructs, using TransIT-LT1 (Mirus Bio LLC, Madison, WI, USA) according to the protocol recommended by the manufacturer.
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S-methionine/cysteine metabolic labeling HEK293 cells were transfected as described in Section 2.10 and then cycloheximide (100 μg/ml) was added to a cell medium for 1 h. Then the medium was replaced by Met/Cys-free DMEM (Sigma-Aldrich) supplemented with 2 mM L-glutamine and 100 μg/ml cycloheximide. After 1 h, the medium was replaced by Met/Cys-free DMEM supplemented with 2 mM L-glutamine and 10 μCi/ml [ 35 S]-L-Met/Cys Protein Labeling Mix (Hartmann Analytic GmbH). After 1 h, radiolabeled medium was removed and cells were washed and lysed as described in Section 2.3. Similar amounts of radioactive lysates were subjected to SDS-PAGE, blotted and the total labeling was measured using the Cyclone Plus Storage PhosphorSystem.
Statistical analysis
Data are presented as means + SD and mean differences were analyzed using t-test. A p b 0.05 was considered as statistically significant.
Results
j-Subunit of eIF3 is a new interactor and substrate of CK2
HEK293, Hela and LAMA84 cells were analyzed in experiments aimed at identifying new CK2 substrates. Cellular lysates were immunoprecipitated with an antiserum raised against the human CK2α C-terminus. Immunocomplexes were then phosphorylated in a medium containing [γ-33 P]ATP. Fig. 1A shows that different coimmunoprecipitated proteins are 33 P-phosphorylated including the expected CK2 regulatory β-subunit (lanes 1,4,7). The strong inhibition of the 33 P-phosphorylation induced by in vitro addition of the CK2 selective and potent inhibitor CX-4945 [25] demonstrates that most proteins are specifically phosphorylated by the constitutively active CK2 (lanes 2, 5, 8) . Consistently, addition of staurosporine at a concentration ineffective toward CK2 but able to inhibit most protein kinases [26] does not affect the protein phosphorylation extent (Fig. 1A, lanes 3,6,9 ). The radioactive protein displaying a MW of about 35-38 kDa, which is highly phosphorylated and present in all the analyzed immunoprecipitates, was excised from the gel, digested by trypsin and analyzed by mass spectrometry. The analysis showed that, among the identified proteins, the j-subunit of the eukaryotic translation initiation factor 3 (eIF3j) (MW = 29,159) displayed the highest mascot score (see Supplementary Materials and Methods and Supplementary Table 1 ). The occurrence of an interaction between CK2 and eIF3j was further supported by the presence of CK2α and CK2β subunits in eIF3j-immunoprecipitates obtained from HEK293 cell lysates (Fig. 1B) . The recognition of the co-immunoprecipitated CK2 subunits was confirmed by running recombinant CK2 holoenzyme (α 2 β 2 ) in parallel with the eIF3j-immunoprecipitates. The identification of eIF3j as a new substrate of CK2 was strengthened by in vitro phosphorylation experiments performed with eIF3j-immunoprecipitates showing that j-subunit is phosphorylated by its interactor CK2. The kinase co-immunoprecipitated with eIF3j (upper panel of 
CK2 phosphorylates eIF3j at Ser127
To check if eIF3j is phosphorylated by CK2 inside the cell, HEK293 cells were treated with vehicle or CX-4945 for 5 h and then lysed. Lysate proteins were immunoprecipitated with anti-eIF3j antibody and the immunocomplexes were subjected to SDS-PAGE. Protein bands corresponding to j-subunit were excised and digested with trypsin. Resulting phoshopeptides were enriched using TiO 2 microcolumns and analyzed by tandem mass spectrometry, as described in Section 2.6. Fig. 2 shows the extracted ion chromatograms for several identified peptides belonging to eIF3j. The eIF3j phosphopeptide LQEEpSDLELAK was identified in the control sample (panel A) but not in the sample immunoprecipitated from cells treated with the CK2 inhibitor CX-4945 (panel B). The ion at m/z = 677.8087 is indeed detectable only in the control experiment, and it is absent in the sample derived from cells treated with CX-4945, while all other ions are present in both samples with similar intensities. The MS/MS spectrum of the ion at m/z = 677.8087 (Fig. 2C) confirms the identification of the eIF3j tryptic phosphopeptide LQEEpSDLELAK containing the residue Ser127, which is located in a sequence matching the CK2 consensus, which is S/T-X-X-Acidic residue [16, 27] .
Inhibition of CK2 increases its binding to eIF3j
Next we assessed whether the inhibition of CK2 activity might affect the interaction occurring between the kinase and eIF3j. To this purpose, HEK293 cells were untreated or treated with CX-4945 or quinalizarin (Q1), two structurally unrelated CK2 inhibitors. Western blot analysis of cellular lysates demonstrates that CX-4945 and Q1 strongly reduce the phosphorylation extent of Akt1 Ser129, a specific target of CK2 [28] (about 80% and 65%, respectively), while they do not change the protein-level of CK2α, CK2β and eIF3j (Fig. 3A) . Cellular lysates were then immunoprecipitated with anti-CK2α antibody. Interestingly, while cell treatment with CX-4945 or quinalizarin does not affect the interaction of the kinase with the eIF3 subunits eIF3b and eIF3d, it causes an about 3-fold increase of eIF3j co-immunoprecipitation (Fig. 3B) . This finding is confirmed by eIF3j-immunoprecipitates showing a great enhancement of CK2α and CK2β co-immunoprecipitation in inhibitor-treated as compared to untreated cells, while the amounts of co-immunoprecipitated eIF3b and eiF3d are unchanged (Fig. 3C) .
To assess whether eIF3j is bound directly to CK2α and/or CK2β, preliminary experiments were performed by down-regulating separately the amount of these two CK2 subunits in HEK293 cells by RNAinterference experiments. Cellular protein-level of CK2α and CK2β was reduced of about 48% and 43%, respectively ( On the contrary, CK2β-downregulation causes a substantial reduction of eIF3j interaction with both CK2 subunits, suggesting that the regulatory β-subunit might play a role as a linker between eIF3j and the CK2 catalytic α-subunit.
CK2-phosphorylation of j-subunit promotes its interaction with eIF3 complex
To get further insight into the interaction occurring between CK2 and eIF3j, HEK293 cells, treated with vehicle or CX-4945, were first lysed and subjected to sucrose gradient centrifugation in the presence of MgCl 2 as described elsewhere [2, 8] . Under these conditions, most eIF3j is detectable in the low-density fractions, dissociated from the eIF3 complex (unpublished data and Ref. [2] ). To recover the j-subunit included in the eIF3 complex, cells were therefore lysed and loaded on glycerol gradients as detailed in Section 2.7. In control cells, a part of the eIF3 complex appears in the high-density fractions of the gradient, bound to the 40S ribosomal subunit as indicated by the cosedimentation and the co-immunoprecipitation of the S6 ribosomal protein (rpS6) with the eIF3 subunits b, c, d and j (fractions 1-4 of Fig. 4A , and Ctrl of Fig. 4C, respectively) . Most of the complex is detectable in the gradient fractions containing protein complex(es) displaying a molecular weight higher than 400 kDa (Fig. 4A, fractions 6-9 ). The distribution of CK2α and CK2β subunits shows that only a small amount of the protein kinase co-migrates with the eIF3 complex in fractions 7-9 ( Fig. 4A) , while the majority of CK2 participates in complex(es) displaying a lower molecular weight (fractions 10-13). Notably, cell treatment with the CK2 inhibitor CX-4945 induces the dissociation of a large amount of j-subunit from the eIF3 complex both bound or unbound to the 40S subunits (Fig. 4B) and its shift toward the lowdensity region of the gradient, where CK2α and CK2β are also detectable (fractions [11] [12] [13] [14] . The finding that cell treatment with CX-4945 does not affect the protein-level of CK2 (Fig. 3A) suggests that eIF3j migration is induced only by inhibition of the kinase activity.
The effect of cell treatment with CX-4945 was further elucidated by immunoprecipitating specific fractions of the gradients. Immunoprecipitation of rpS6 from the high-density region of the gradient (fractions 2 and 3) (Fig. 4C) demonstrates that CK2-inhibition triggers the detachment of eIF3j from the protein-complex containing the other eIF3 subunits and the 40S ribosomal subunit. Immunoprecipitation of eIF3j (Fig. 4D ) supports the previous finding that cell treatment with CX-4945 induces an increased interaction of eIF3j with inactive CK2 (Fig. 3) . This is evident for both the populations of eIF3j, the one bound to the eIF3 complex (Fig. 4D, fractions 7,8) and that migrated to the low-density region of the gradient (fractions 12,13). The outcome that CK2 inactivation correlates with the j-subunit dissociation from the eIF3 complex supports the view that the CK2-phosphorylation of eIF3j is a prerequisite for the binding of this subunit to eIF3 complex.
Considering the importance of cell translational activity in cancer, the interplay occurring between CK2 and eIF3j was further analyzed also in LAMA84, a chronic myeloid leukemia cell line presenting an aberrant protein synthesis [29] . Fig. 1A demonstrates that eIF3j is an interactor and an in vitro substrate of CK2 also in LAMA84 cells. Moreover, as previously shown in HEK293 cells (Fig. 3) , treatment of these leukemic cells with CX-4945 causes an enhanced interaction of eIF3j with CK2. In comparison with control cells, CK2-inhibition in LAMA84 cells correlates with a strong increase of the co-immunoprecipitated amount of eIF3j (Fig. 5A ) or CK2α and CK2β (Fig. 5B ) detectable in CK2α-or eIF3j-immunoprecipitates, respectively. Glycerol gradients of LAMA84 cellular lysates were then performed. Differently from what were found in HEK293 cells (Fig. 4A) , in control LAMA84 cells (Fig. 5C ) the eIF3 complex appears in the high-density fractions (1) (2) (3) (4) (5) (6) (7) (8) of the gradient and most of it co-sediments with the 40S ribosomal subunits, indicating the assembly of the preinitiation complex (fractions 1-4). A substantial amount of eIF3j is also present in the low-density portion of the gradient (fractions [10] [11] [12] [13] [14] , where CK2α and CK2β are also detectable. Consistent with the results obtained with HEK293 cells, treatment of LAMA84 cells with CX-4945 (Fig. 5D) correlates with the dissociation of a substantial amount of eIF3j from the preinitiation complex and its migration to the low-density fractions 11-15, which contain also the protein kinase CK2.
The role played by CK2 in promoting the interaction of eIF3j with the other eIF3 subunits was also confirmed by knocking down CK2α expression in HEK293 cells by RNA interference experiments. A decrease of more than 40% of both CK2α protein-level and activity was observed following CK2α silencing (Fig. 6A and B, respectively) . Glycerol gradients of cell lysates demonstrate that cells transfected with nonspecific siRNA (Ctrl) exhibit a sedimentation profile similar to that of untreated cells (compare Figs. 6C and 4A ). In contrast, CK2α downregulation induces the dissociation of an aliquot of j-subunit from eIF3 complex (Fig. 6D) confirming the outcome observed by inhibiting CK2 activity with CX-4945 (Fig. 4B) .
S127A mutation of eIF3j affects the subunit interaction with eIF3 complex and impairs the protein synthesis
To further analyze the role played by eIF3j Ser127, HEK293 cells were transfected with MYC-tagged cDNA of either wild type eIF3j or the mutated counterpart containing Ser127 replaced by Ala. Fig. 7A shows that transfected cells overexpress the same amount of Myctagged proteins without affecting the expression of endogenous eIF3 subunits b and d. To reinforce the concept that Ser127 is indeed a CK2 target, wild type and mutant eIF3j were immunoprecipitated by antiMyc antibody and the immunocomplexes were added to a phosphorylation medium containing recombinant CK2. The finding that S127A-eIF3j mutant is only slightly 33 P-phosphorylated by the kinase in comparison with the wild type subunit proves that Ser127 is the main site of CK2-phosphorylation (Fig. 7B) . We then analyzed the interaction occurring between overexpressed j-subunit and endogenous eIF3 subunits by immunoprecipitating wild type or mutant Myc-eIF3j with anti-Myc antibody (Fig. 7C) . S127A mutation induces a substantial decrease of eIF3b, eIF3c and eIF3d binding to mutated eIF3j in comparison with the interaction detectable with wild type eIF3j, confirming the role played by Ser127 in eIF3j binding to the eIF3 complex. Consistently, the parallel eIF3b-immunoprecipitation (Fig. 7D) shows a similar coimmunoprecipitation of eIF3c and eIF3d in the two differently transfected cells, while the binding of the Myc-tagged proteins is different, being the amount of coimmunoprecipitated S127A-eIF3j lower than that of wild type eIF3j. The deletion of the eIF3j ortholog HCR1 in Saccharomyces cerevisiae has been demonstrated to cause a significant decrease of the yeast growth rate [10, 30] , while the knocking down of eIF3j by siRNA in mammalian cells was found less effective on translational rate and cellular growth [2] . We wanted to assess whether the efficiency of the protein synthesis was affected by eIF3j S127A mutation. HEK293 cells, transfected with empty vector or overexpressing a similar amount of wild type or mutated Myc-eIF3j (Fig. 7E, upper panel) , were pulsed in the presence of a radiolabeled methionine and cysteine mix before quantification of total protein labeling. Fig. 7E (bar graph) shows that the overall protein synthesis of control cells (Ctrl) is not affected by the overexpression of wild type Myc-eIF3j (WT). Notably, expression of S127A-eIFj mutant is accompanied by more than 30% reduction of the translation efficiency in comparison with cells transfected with wild type eIF3j, demonstrating that eIF3j Ser127 plays a regulatory role in the translational control of protein synthesis.
Discussion
In this study we demonstrate by means of both immunoprecipitation experiments and mass spectrometry analyses that eIF3 complex is associated with CK2 in human cells and that eIF3j subunit is a new substrate of this protein kinase (Fig. 1) . Although two eIF3 polypeptides isolated from rabbit reticulocytes and displaying the molecular weights of 70,000 and 120,000, have been described as the first CK2 substrates in very early studies [31, 32] , no other evidence has been subsequently provided that human eIF3 is regulated by CK2. It has been reported that eIF3c is a substrate of CK2 in plants [33] and that the yeast homologues of eIF3b and eIF3c are phosphorylated by CK2 [34] . Here we demonstrate that CK2 phosphorylates the eIF3 j-subunit at Ser127, a residue located in the sequence LQEEpSDLELAK matching the CK2 phosphorylation consensus sequence. This is specified by a carboxylic or pre-phosphorylated amino acid at position n + 3 with respect to the target residue and optimized by additional acidic amino acids in the proximity of the phosphorylatable residue [16, 27] . Phosphoproteomic studies have already demonstrated that eIF3 Ser127 is phosphorylated in cells [35] [36] [37] [38] . Our results show that this residue is specifically phosphorylated by CK2 since the eIF3j Ser127 phosphorylation does not occur in cells treated with the CK2-inhibitor CX-4945 ( Fig. 2) and the phosphorylation of eIF3j is almost abrogated when Ser127 is replaced by Ala (Fig. 7B) . Phospho-proteomic analyses have also shown that, like eIF3j, other mammalian eIF3 subunits contain phospho-residues located in sequences potentially susceptible to phosphorylation by CK2 [35, 37] , suggesting a global role of CK2 in the regulation of eIF3, a central player in the mechanism of translational control, whose alterations may lead to either cell malignancy or cell death [39, 40] . With regard to this, the notion that CK2 is abnormally elevated in a wide variety of tumors, where it is exploited as an antiapoptotic and pro-survival agent, suggests that the oncogenic potential of this protein kinase might also rely on its ability to functionally affect eIF3, whose contribution to oncogenesis and maintenance of the malignant phenotype has been amply demonstrated [41] [42] [43] . Cell treatment with CK2 inhibitors demonstrates that, once the kinase activity is inhibited, CK2 greatly enhances its binding to j-subunit (Figs. 3 and 5) . Notably, this binding increase is partially due to a subpopulation of j-subunit molecules that dissociate from eIF3 complex following CK2 inhibition and co-migrate with inactive CK2 as demonstrated by differential sedimentation in glycerol gradients obtained with HEK293 and chronic myeloid leukemic LAMA84 cells (Figs. 4 and 5) . The finding that treatment of LAMA84 cells with CX-4945 induces the detachment of eIF3j from the preinitiation complex suggests that this event is involved in the decreased viability caused in these leukemic cells by CX-4945-inhibition of CK2 activity [44] . Consistently, the down-regulation of cellular CK2 by knocking-down the CK2α catalytic subunit in HEK293 cells by siRNA induces a similar dissociation of j-subunit from eIF3 complex ( Fig. 6C and D) . These results are in agreement with studies showing that eIF3j is a loosely associated subunit, easily detachable from the rest of the eIF3 complex during purification and detectable in cells also as unbound protein [9, 12] . The finding that CK2 inhibition promotes both the dissociation of j-subunit from eIF3 and its increased binding to the kinase suggests that: i) nonphosphorylated eIF3j binds to CK2 more than its phosphorylated counterpart; ii) eIF3j, once phosphorylated by CK2, dissociates from the kinase; iii) eIF3j dissociation from the eIF3 complex is likely caused by the reduced CK2 activity and not by the decreased protein-level of the kinase (Fig. 6) as demonstrated in cells treated with CX-4945 (Figs. 4 and 5) , that contain an unchanged amount of CK2 (Fig. 3A) . This hypothesis is also supported by the reduced interaction of j-subunit with the eIF3 complex occurring when active CK2 is unable to phosphorylate eIF3j due to Ser127Ala mutation (Fig. 7) ; iv) CK2-phosphorylation of eIF3j triggers the interaction of this subunit with the other complex subunits, an event that has been described to play a stabilizing role in forming the eIF3 complex [9, 10, 13] as well as in the eIF3 binding with the decoding center of the 40S ribosomal subunits [8, 9, [11] [12] [13] . It has been also recently shown that eIF3j and eIF3 complex bind cooperatively to the 40S ribosomal subunit and that the whole eIF3 complex is critical for the high affinity binding of eIF3j on the 43S preinitiation complex [13] .
In mammals, the recruitment and positioning of Met-tRNAi on the small 40S ribosomal subunit to form the 43S preinitiation complex are mediated and stabilized by the eukariotic initiation factors eIF1, eIF1A, eIF2, eIF3 and eIF5 [45, 46] . It has been demonstrated that CK2 interacts with and phosphorylates human eIF2β and eIF5 affecting the translation initiation complex formation and the cellular growth rate [47, 48] . Our results showing that also eIF3j is phosphorylated by CK2 reveal that most of the initiation factors acting in mammalian preinitiation complex are regulated by CK2.
The key role played by eIF3j Ser127 in eIF3 complex assembly and translation initiation machinery is further supported by the data obtained upon transfection of HEK293 cells with a plasmid encoding S127A-eIF3j mutant. We found that the amount of endogenous eIF3 subunits interacting with S127A-eIF3j is much lower than that detected in cells overexpressing wild type eIF3j (Fig. 7C and D) . Our results also show that protein synthesis is markedly reduced in cells containing S127A-eIF3j mutant in comparison with cells overexpressing wild type eIF3j (Fig. 7E) , consistent with the notion that the main mechanism regulating the overall rate of protein synthesis involves the phosphorylation of the initiation factors [39] .
Collectively taken, our data demonstrate that CK2 phosphorylation of eIF3j at Ser127 regulates the j-subunit association with eIF3 complex and underscore the crucial role of CK2 in the initiation of protein synthesis.
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